GEDSA fully supports the recent letter on "The Use of Enteral Device Connectors that Reduce Risk of Misconnection and Patient Injury" issued by the FDA on September 7, 2018 (https://tinyurl.com/FDA-80369-3) and applauds the FDA for its release. GEDSA expects this letter to serve as the catalyst for accelerated U.S. market adoption of safer compliant connectors, as defined by the Int er na tional St andards Organization (ISO) 80369-3, commonly known by the federally registered trademarked name ENFit®. GEDSA and its supporting organizations urge manufacturers, distributors/suppliers and health care providers to actively participate in the adoption of new ENFit® connectors as called for in the FDA's letter.